1-4 of 4
Stefan Klein, MD
Close
Save search
Sort by
Journal Articles

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Free
Christoph Röllig, MD MSC, Michael Kramer, M.Sc., Christoph Schliemann, Jan-Henrik Mikesch, MD, Björn Steffen, MD, Alwin Krämer, MD, Tim Sauer, MD, Mathias Hänel, MD, Regina Herbst, MD, Kerstin Schäfer-Eckart, MD, Richard Noppeney, MD, Edgar Jost, MD, Tim H Brümmendorf, MD, Stefan W Krause, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Sebastian Scholl, Andreas Hochhaus, MD, Lars R. Fransecky, MD, Martin Kaufmann, MD, Andreas Neubauer, MD, Dirk Niemann, MD, Markus Schaich, MD, Norbert Frickhofen, MD, Alexander Kiani, Frank Heits, MD, Ulrich Krümpelmann, Ulrich Kaiser, MD, Johannes Kullmer, Maxi Wass, MD, Stefan Klein, MD, Malte Von Bonin, Jan Moritz Middeke, MD, Christian Thiede, MD, Friedrich Stoelzel, MD, Johannes Schetelig, MDMSc, Gerhard Ehninger, MD, Claudia D Baldus, Carsten Müller-Tidow, MD, Uwe Platzbecker, Hubert Serve, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 13.
https://doi.org/10.1182/blood-2019-123717
Published: 2019
Journal Articles

The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD

Free
Eva M Weissinger, MD, Metzger Jochen, PhD, Michael Schleuning, MD, Christoph Schmid, Diethelm Messinger, Gernot Beutel, MD, Eva-Maria Wagner, MD, Johannes Schetelig, MD, Herrad Baurmann, MD, Andreas Rank, MD, Friedrich Stolzl, MD, Kerstin Schäfer-Eckhard, MD, Karin Westphal, Wolfgang Bethge, MD, Donald w. Bunjes, MD, Daniela Heidenreich, MD, Stefan Klein, MD, Daniel Wolff, MD, Ernst Holler, MD, Hans H Kreipe, MD PhD, Danny Jonigk, Irina Türüchanow, Clara Rothmann, Julia Raad, Annika Durban, Iyas Hamwi, MD, Steve Ehrlich, MD, Patrick Schweier, Jurgen Krauter, MD, Michael Stadler, MD PhD, Arnold Ganser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 512.
https://doi.org/10.1182/blood.V130.Suppl_1.512.512
Published: 2017
Journal Articles

Treatment of Relapse of MDS, AML and CMML after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions - Results from the First Interim Analysis of the Azalena-Trial (NCT02472691)

Free
Thomas Schroeder, MD, Christina Rautenberg, MD, Max Christopeit, Matthias Stelljes, MD, Eva Schmidt, Stefan Klein, MD, Christof Scheid, MD, Dietrich W Beelen, MD PhD, Kathrin Nachtkamp, MD, Rainer Haas, MD, Ulrich Germing, MD, Nicolaus Kröger, Guido Kobbe, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4521.
https://doi.org/10.1182/blood.V130.Suppl_1.4521.4521
Published: 2017
Journal Articles

Systemic Mastocytosis with Associated Acute Myeloid Leukemia (SM-AML): a Poor-Risk Multi-Mutated Disease That Follows a Distinct Diagnostic Algorithm and Requires High-Dose Stem Cell-Targeting Therapy

Free
Mohamad Jawhar, MD, Sebastian Kreil, MD, Juliana Schwaab, Khalid Shoumariyeh, MD, Lambert L.F. Span, Stephan Fuhrmann, Nicole Naumann, Florian Nolte, MD, Daniela Heidenreich, MD, Nadine Z. Müller, MD, Hans-Peter Horny, Karl Sotlar, Torsten Haferlach, MD, Boris Kubuschok, Karsten Spiekermann, Michael Heuser, MD, Georgia Metzgeroth, MD, Alice Fabarius, Stefan Klein, MD, Wolf-Karsten Hofmann, MD, Nicholas C.P. Cross, PhD, Manja Meggendorfer, PhD, Hanneke Kluin-Nelemans, MD PhD, Wolfgang R. Sperr, MD, Peter Valent, MD, Andreas Reiter, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2916.
https://doi.org/10.1182/blood.V130.Suppl_1.2916.2916
Published: 2017